Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Danish Study of Low-dose Interferon Alpha Versus Hydroxyurea in the Treatment of Philadelphia Chromosome Negative (Ph-)Chronic Myeloid Neoplasms.

NCT01387763 is registered in ClinicalTrials.gov with Thomas Stauffer Larsen as lead sponsor.

NCT NCT01387763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01387763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Danish Study of Low-dose Interferon Alpha Versus Hydroxyurea in the Treatment of Philadelphia Chromosome Negative (Ph-)Chronic Myeloid Neoplasms.
Lead sponsor
Thomas Stauffer Larsen
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2012
Completion date
June 30, 2020
Enrollment
202 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

essential thrombocythemia, polycythemia vera, primary myelofibrosis